Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novel dietary-induced mouse model of NASH with severe fibrosis

Nov. 11, 2019

Novel nonhuman primate model of induced colitis

Nov. 8, 2019

Morphic Therapeutic identifies new MAdCAM antagonists

Nov. 5, 2019

iRhom2 is fibrosis friend, not foe

Nov. 5, 2019

Pivotal study of budesonide oral suspension in eosinophilic esophagitis achieves endpoints

Oct. 29, 2019

Phase II results presented for TIMP-GLIA in celiac disease

Oct. 29, 2019

New phase II trial investigates JNJ-67864238 for moderate to severely active Crohn's disease

Oct. 28, 2019

Phase IIb data for upadacitinib as an induction therapy for patients with UC

Oct. 28, 2019

Ozanimod demonstrates early histologic improvement in patients with active CD

Oct. 28, 2019

Pliant enters collaboration and license agreement with Novartis for PLN-1474 in NASH

Oct. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...